Post-earnings recap
Reported
Thu, Oct 30, 2025
EPS actual
$0.67
EPS est.
$0.59
EPS surprise
+13.18%
1-day move
+0.96%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Edwards Lifesciences reported a better-than-expected EPS for the quarter, which contributed to a slight increase in the stock price. However, there was no revenue data provided, leaving some uncertainty about overall performance. The market reacted positively to the EPS surprise, indicating investor confidence in the company's earnings potential.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.67 | N/A | +13.18% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.